Home/Recalls/FDA-D-0399-2026
FDA DrugsClass II

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescript...

Published: March 11, 2026Recall ID: D-0399-2026Category: drugsCountry: US

Reason for Recall / Hazard

Failed Dissolution Specifications

Product Description & Identification

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

Additional Source Details

FieldValue
CityMorgantown
StateWV
Openfda › Nui › 1N0000175607
Openfda › Nui › 2M0018962
Openfda › UniiEH28UP18IF
Openfda › RouteORAL
Openfda › Rxcui › 1197843
Openfda › Rxcui › 2197844
Openfda › Rxcui › 3197845
Openfda › Rxcui › 4403930
Openfda › Rxcui › 5404058
Openfda › Rxcui › 6404061
Openfda › Rxcui › 7404064
Openfda › Rxcui › 82711694
Openfda › Spl id8105505f-9df6-4bc4-b201-7281a2d3af00
Openfda › Brand nameAMNESTEEM
Openfda › Spl set idb2cb63c9-f825-4991-9a2c-6260f1bbcc2c
Openfda › Package ndc › 10378-6611-85
Openfda › Package ndc › 20378-6611-93
Openfda › Package ndc › 30378-6612-85
Openfda › Package ndc › 40378-6612-93
Openfda › Package ndc › 50378-6613-85
Openfda › Package ndc › 60378-6613-93
Openfda › Package ndc › 70378-6614-85
Openfda › Package ndc › 80378-6614-93
Openfda › Product ndc › 10378-6611
Openfda › Product ndc › 20378-6612
Openfda › Product ndc › 30378-6613
Openfda › Product ndc › 40378-6614
Openfda › Generic nameISOTRETINOIN
Openfda › Product typeHUMAN PRESCRIPTION DRUG
Openfda › Pharm class csRetinoids [CS]
Openfda › Substance nameISOTRETINOIN
Openfda › Pharm class epcRetinoid [EPC]
Openfda › Manufacturer nameMylan Pharmaceuticals Inc.
Openfda › Application numberANDA075945
Openfda › Is original packagertrue
Event id98477
Address 11311 Pineview Dr
Address 2N/A
Code infoLot #: 3116110, 3116130, Exp. Date 07/2026
Postal code26505-3276
Report date20260311
Product typeDrugs
Product quantity34850 blister packs
Reason for recallFailed Dissolution Specifications
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260224
Initial firm notificationLetter
Center classification date20260319

Overview

  • Recalling FirmMYLAN PHARMACEUTICALS INC
  • StatusOngoing
  • Risk LevelClass II
  • DistributionNationwide within the United States
Official Agency Alert